Answers are grounded in this paper and cite their sources.
Asthma and atopic dermatitis (AD) are common chronic inflammatory conditions that often begin in childhood and may persist into adolescence or adulthood. Understanding their temporal and regional patterns among children, adolescents, and young adults is important for informing age-specific prevention and management strategies. This study aimed to assess the global burden and temporal trends of asthma and AD among children, adolescents, and young adults aged 0–24 years from 1990 to 2021. Modelled estimates of incidence, prevalence, deaths, and DALYs among individuals aged 0–24 years from 1990 to 2021 were extracted from GBD 2021. Joinpoint regression was used to calculate average annual percentage change (AAPC) and identify significant trend shifts. Analyses were conducted by sex, age, sociodemographic index (SDI), region, and country. From 1990 to 2021, GBD 2021 modelled estimates suggested overall decreases in the incidence, prevalence, and DALYs of asthma and AD globally. However, the point estimates for the AAPCs of asthma incidence and prevalence were slightly positive during 2019–2021 (AAPC: 0.03, 95% CI: −0.16 to 0.23; AAPC: 0.40, 95% CI: −0.04 to 0.84, respectively). Nevertheless, the corresponding 95% CIs crossed zero, indicating that these changes were not statistically significant and should not be interpreted as confirmed increasing trends. The estimated burden of asthma and AD varied by sex and age group. Regionally, the incidence of AD is decreasing in most countries, but still increasing in some regions (most significant in the European Region AAPC = 0.22 [95% CI: 0.20, 0.23]), and asthma and AD deaths and DALYs are higher in countries with lower SDI. Future projections suggested a possible increase in asthma prevalence and a decrease in AD prevalence under the assumption that historical trends continue. Despite global declines in asthma and AD burden among individuals aged 0–24 years, many countries showed rising trends, highlighting inequalities in disease control. The estimated burden varied substantially across SDI levels, and different indicators showed different SDI-related patterns. Not applicable.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: